Literature DB >> 21692206

The influence of phacoemulsification on corneal endothelial cells at varying blood glucose levels.

RuiMing Yang1, Xhangyin Sha, Mingbing Zeng, Yingqian Tan, Yu Zheng, Feihong Fan.   

Abstract

PURPOSE: To investigate the influence of phacoemulsification on corneal endothelial cells in diabetes patients and normal controls.
METHODS: Phacoemulsification and intraocular lens implantation were performed on 75 patients with diabetic cataract (126 eyes) who were divided into two groups: Experimental group 1 (Glu ≤ 6mmol/L); Experimental group 2 (Glu 6-10 mmol/L) and 65 non-diabetic controls (112 eyes). The density and percentage of hexagonal cells and coefficient of variation of the corneal endothelia were measured before surgery and 1 day, 1 month and 3 months postoperatively.
RESULTS: There was no statistical difference in the density and percentage of hexagonal cells and coefficient of variation of the corneal endothelia prior to phacoemulsification (P>0. 05) between the three groups. The density and percentage of hexagonal cells of the corneal endothelia decreased significantly after surgery in all three group (P<0.05), while the Coefficient of variation increased in all groups (P< 0.05). The rate of loss of corneal endothelial cells in the diabetic groups was significantly higher than for the control group (P<0.05), the percentage of hexagonal cells in the diabetic groups was significantly lower than for the control group (P<0.05), and the coefficient of variation in the diabetic groups was significantly higher than for the control group (P<0.05) at 1 day, 1 month and 3 months post-operatively. There was no statistical difference between the two diabetic groups in terms of these post-operative measurements.
CONCLUSION: The corneal endothelium of diabetic patients is more prone to damage from phacoemulsification. It is advisable to evaluate the corneal endothelium routinely prior to phacoemulsification, particularly in diabetic persons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692206     DOI: 10.3969/j.issn.1000-4432.2011.02.018

Source DB:  PubMed          Journal:  Eye Sci


  8 in total

Review 1.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 2.  Cataract Surgery Considerations for Diabetic Patients.

Authors:  Jonathan A Go; Christina A Mamalis; Sumitra S Khandelwal
Journal:  Curr Diab Rep       Date:  2021-12-30       Impact factor: 4.810

3.  Comparison of corneal endothelial cell changes after phacoemulsification between type 2 diabetic and nondiabetic patients.

Authors:  Jin-Ho Joo; Tae Gi Kim
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

Review 4.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

5.  Clinical evaluation of corneal changes after phacoemulsification in diabetic and non-diabetic cataract patients, a systematic review and meta-analysis.

Authors:  Yizhen Tang; Xinyi Chen; Xiaobo Zhang; Qiaomei Tang; Siyu Liu; Ke Yao
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

6.  Risk factors for endothelial cell damage in diabetics after phacoemulsification.

Authors:  Niruban Ganesan; Renuka Srinivasan; K Ramesh Babu; Muthukrishnan Vallinayagam
Journal:  Oman J Ophthalmol       Date:  2019 May-Aug

7.  Change in corneal endothelial cell density after phacoemulsification in patients with type II diabetes mellitus.

Authors:  Muhammad Khalid; Muhammad Kashif Hanif; Qamar Ul Islam; Muhammad Asim Mehboob
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 8.  Cataract surgery in diabetes mellitus: A systematic review.

Authors:  Aditya Kelkar; Jai Kelkar; Hetal Mehta; Winfried Amoaku
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.